It is now widely recognised that insulin resistant states, such as T2DM, cardiovascular disease and the metabolic syndrome, are characterised by a low-grade systemic inflammation, as well as inflammatory changes in adipose tissue [6,13,32,33]. The gene discussed is INS; the disease is metabolic syndrome.